The US Food & Drug Administration (USFDA) has approved the Abbreviated New Drug Application (ANDA) filed by Granules India Ltd., for Loratadine Tablets USP, 10 mg (OTC).
The approved ANDA is the bioequivalent to the Reference Listed Drug (RLD), Claritin Tablets 10 mg by Bayer HealthCare LLC. Granules India Limited intends to commercialize this product shortly.
Granules India Ltd is currently trading at Rs128.20 up by Rs1.1 or 0.87% from its previous closing of Rs127.10 on the BSE.
The scrip opened at Rs126.90 and has touched a high and low of Rs129 and Rs126.90 respectively. So far 2,49,689 (NSE+BSE) shares were traded on the counter.
The current market cap of the company is Rs3,231.49cr.
For Quick Trial – 8871888787
or mail us here - support@researchicon.com
or visit - http://www.researchicon.com/free-trial
Post a Comment